Lipoxamycin hemisulfate

TargetMol
Product Code: TAR-T26308
Supplier: TargetMol
CodeSizePrice
TAR-T26308-1mg1mg£267.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T26308-2mg2mg£364.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T26308-5mg5mg£565.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T26308-10mg10mg£775.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T26308-25mg25mg£1,131.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T26308-50mg50mg£1,508.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T26308-100mg100mg£1,990.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
Lipoxamycin hemisulfate is an inhibitor of serine palmitoyltransferase (IC50 = 21 nM) with antifungal activity.
CAS:
11075-87-9
Formula:
C38H74N4O14S
Molecular Weight:
843.08
Pathway:
Microbiology/Virology
Purity:
0.9906
SMILES:
OS(O)(=O)=O.CC(C)CCCC(=O)CCCCCCC(=O)CCN(O)C(=O)[C@@H](N)CO.CC(C)CCCC(=O)CCCCCCC(=O)CCN(O)C(=O)[C@@H](N)CO
Target:
Antifungal

References

1. S M Mandala, et al. Inhibition of Serine Palmitoyl-Transferase Activity by Lipoxamycin. J Antibiot (Tokyo). 1994 Mar;47(3):376-9. 2. Whaley HA. The structure of lipoxamycin, a novel antifungal antibiotic. J Am Chem Soc. 1971 Jul 28;93(15):3767-9. 3. Roy SK, et al. Isolation, structural elucidation and biological properties of neoenactins B1, B2, M1 and M2, neoenactin congeners. J Antibiot (Tokyo). 1987 Mar;40(3):266-74. 4. Whaley HA, Sebek OK, Lewis C. Production, isolation, characterization, and evaluation of lipoxamycin, a new antifungal agent. Antimicrob Agents Chemother (Bethesda). 1970;10:455-61.